Back to search

Article

Post-biopsy cell-free DNA from blood: an open window on primary prostate cancer genetics and biology

2021-01-19

Abstract excerpt

<title>Abstract</title> <p>BackgroundCirculating cell-free DNA (ccfDNA), released from normal and cancerous cells, is a promising biomarker for cancer detection as in neoplastic patients it is enriched in tumor-derived DNA (ctDNA). ctDNA contains cancer-specific mutations and epigenetic modifications, which can have diagnostic/prognostic value. However, in primary tumors, and in particular in localized prostate c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e37dd6c-e779-540c-af33-7466cb8db94e
DOI
10.21203/rs.3.rs-147849/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Post-biopsy cell-free DNA from blood: an open window on primary prostate cancer genetics and biologyDOI 10.21203/rs.3.rs-147849/v1
Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and BiologySemantic proximity
Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate CancerSemantic proximity
Liquid biopsy with cell free DNA: new horizons for prostate cancer.Semantic proximity
Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesisSemantic proximity
DNA repair deficiency as circulating biomarker in prostate cancerSemantic proximity
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.Semantic proximity
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesisSemantic proximity
The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancerSemantic proximity
Cell-free DNA concentration and fragment size as a biomarker for prostate cancerSemantic proximity
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate CancerSemantic proximity
Clinical determinants for successful circulating tumor DNA analysis in prostate cancerSemantic proximity
Select a neighboring publication to make it the new centre.